Status:
COMPLETED
Physician Survey on Monitoring of Patients Treated With Quetiapine
Lead Sponsor:
AstraZeneca
Conditions:
Schizophrenia
Bipolar Disorder
Eligibility:
All Genders
Brief Summary
A physician survey to document receipt of metabolic educational materials and assess behavior of physicians in following messages communicated through the educational materials
Detailed Description
Assessment of physician behavior regarding metabolic monitoring of patients treated with SEROQUEL® (quetiapine fumarate) Tablets and SEROQUEL® (quetiapine fumarate) Extended Release Tablets in selecte...
Eligibility Criteria
Inclusion
- Physicians targeted to receive the metabolic educational materials and either currently prescribe or have the potential to prescribe SEROQUEL® or SEROQUEL® XR.
Exclusion
- Physicians who have participated in a survey involving SEROQUEL® / SEROQUEL® XR in the past six months are not eligible to participate in this survey.
Key Trial Info
Start Date :
June 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2013
Estimated Enrollment :
800 Patients enrolled
Trial Details
Trial ID
NCT01795326
Start Date
June 1 2013
End Date
September 1 2013
Last Update
January 28 2014
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.